Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06283147 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Risk Assessment and Management Program (RAMP) on Knee Osteoarthritis in Primary Care

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Nov 30, 2025 to May 30, 2026 Trial status changed: Unknown → Completed · Study completion date changed from estimate of Apr 1, 2026 to Jun 30, 2026 · Eligibility criteria expanded, about 6 words · 2 more Show 5 more changesShow less
    • Trial status changed: Unknown → Completed
    • Study completion date changed from estimate of Apr 1, 2026 to Jun 30, 2026
    • Eligibility criteria expanded, about 6 words
    • Publications: details revised at 1 of 1 entry
    • Study description expanded, about 4 words
  2. Changed Registry marked status Unknown; last known: Active, Not Recruiting
  3. Trial status: Recruiting to Unknown Site details revisedv5 Show 1 more changeShow less
    • Site details revised
  4. Start date changed from estimate of Apr 1, 2024 to Apr 8, 2024v4
  5. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1v3 Show 1 more changeShow less
    • Study sites: 0 to 1
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to determine the clinical effectiveness of a Chronic Care Model (CCM) named Risk Assessment and Management Program on Knee OA (RAMP-Knee OA) in adults with knee Osteoarthritis (Knee OA) at 52 weeks. Participants will be screened for eligibility to participate. After confirming eligibility, participants will complete the baseline assessment and be randomized into one of the following groups (n=114 for each group): 1. RAMP Knee-OA group 2. Usual care group Outcomes will be measured at baseline, week 16, week 32, and week 52.
Trial Details
NCT Number NCT06283147
Lead Sponsor Chinese University of Hong Kong
Conditions Knee Osteoarthritis
Enrollment 228 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov